Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |